YEM Search

搜索结果

IFNAR2

靶点ID:TCMBANKGE014239

靶点别名:IFN-R; IFN-alpha-REC; IFNABR; IFNARB; IMD45

靶点描述:interferon alpha and beta receptor subunit 2

染色体:21

染色体位置:21q22.11

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:5433

OMIM_Link:602376

Ensembl_Link:ENSG00000159110; ENSG00000249624

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN037440	Uridine	URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5		244.201

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000018		Digestive System Diseases; Neoplasms; Endocrine System Diseases	Abnormality of the digestive system; Neoplasm	Neoplastic Process	disease
TCMBANKDI000023		Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000035		Digestive System Diseases; Infections	-	Disease or Syndrome	disease
TCMBANKDI001016		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases	-	Disease or Syndrome	disease
TCMBANKDI004054		Pathological Conditions, Signs and Symptoms	-	Neoplastic Process	phenotype
TCMBANKDI005426		Infections	-	Disease or Syndrome	group
TCMBANKDI008305		Digestive System Diseases; Infections	Abnormality of the digestive system; Abnormality of the immune system	Disease or Syndrome	group
TCMBANKDI008636		Infections	-	Disease or Syndrome	disease
TCMBANKDI009231		Pathological Conditions, Signs and Symptoms; Infections	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI009571		Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI010160		Respiratory Tract Diseases	Abnormality of the respiratory system	Disease or Syndrome	group
TCMBANKDI011557		Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI014839		Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases	-	Disease or Syndrome	disease
TCMBANKDI025937		Digestive System Diseases; Infections	-	Disease or Syndrome	disease
TCMBANKDI028459		Congenital, Hereditary, and Neonatal Diseases and Abnormalities	Abnormality of the digestive system; Abnormality of the cardiovascular system; Growth abnormality	Congenital Abnormality	disease